Emblica Officinalis Seed Extract for Cholesterol Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for coronary heart disease and dyslipidemia, including diets and lipid-lowering drugs, fail to safely and effectively reduce harmful LDL cholesterol while maintaining or enhancing beneficial HDL cholesterol levels, often leading to adverse effects and incomplete risk reduction.
Innovation Solution
A medicinal composition derived from the seed extract of Emblica officinalis, rich in polyphenolic and lipophilic components, which reduces total cholesterol, triglycerides, and LDL cholesterol while enhancing HDL cholesterol levels, improving the HDL to total cholesterol ratio, and modulating other cardiovascular risk factors without affecting CoQ10 levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If lipid-lowering drugs are used to reduce LDL cholesterol, then LDL cholesterol levels are reduced, but HDL cholesterol levels decrease and adverse effects occur
Solution Approach 1:
The patent extracts and utilizes specifically the seed portion of Emblica officinalis, separating it from the conventional fruit extract approach. This extraction of the seed component yields a composition that selectively reduces LDL cholesterol while preserving HDL cholesterol, resolving the contradiction by isolating the beneficial seed-specific compounds that do not cause the adverse HDL reduction seen with conventional drugs
Solution Approach 2:
The patent changes the chemical parameter basis from conventional lipid-lowering drug mechanisms to polyphenolic and lipophilic components specific to Emblica officinalis seed extract. This parameter change in the active ingredients enables selective LDL reduction without the harmful effect on HDL cholesterol, maintaining reliability while achieving the desired lipid profile modification
2Duration of action of stationary object
If conventional treatments are used to lower cholesterol, then total cholesterol is reduced, but cardiovascular risk reduction is incomplete
Solution Approach 1:
The Emblica officinalis seed extract composition performs multiple functions simultaneously: it reduces total cholesterol, specifically lowers LDL cholesterol, enhances HDL cholesterol, and reduces cardiovascular risk factors. This multi-functionality addresses the incomplete risk reduction of conventional treatments by providing comprehensive cardiovascular protection through a single therapeutic agent
Solution Approach 2:
The patent utilizes a composite of polyphenolic and lipophilic components from Emblica officinalis seed extract, creating a synergistic composition that achieves comprehensive cholesterol management and cardiovascular risk reduction. This composite material approach enables simultaneous multiple therapeutic effects that conventional single-mechanism drugs cannot achieve
Data Source
AI summary
An extract of seeds of Emblica officinalis which has triterpenoids and hydroxycinnamic acids is provided. A blend of extracts of seeds of Emblica officinalis which includes an extract of seeds of Emblica officinalis having triterpenoids and hydroxycinnamic acids and an extract of seeds of Emblica officinalis having fatty acids, such as, alpha linolenic acid, linoleic acid and oleic acid is provided. Methods of preparing the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided. Methods of treatment administering the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided.